Infuse life, prevent complications
Potential complications can make intravenous therapy lethal. It is important to know the risks and then integrate the right practices in vascular access management routine.
Discovery. Diagnostics. Delivery.
Can be accessed on our Customer Learning Portal. The e-learning courses offer detailed and solution focused training to help better understand how to solve for common scenarios.
Discovery. Diagnostics. Delivery.
Can be accessed on our Customer Learning Portal. The e-learning courses offer detailed and solution focused training to help better understand how to solve for common scenarios.
Experts from around the globe describe the intersection between patient and healthcare worker safety, focusing on techniques to improve both occupational and public health.
Webinar Objectives:
- Describe the current global impact of bloodborne disease
- Describe occupational exposure incidents for needlesticks and sharps injuries
- Define safety as a function of focus for both patient and health worker, to reduce overall bloodborne disease
- Provide guidance on the importance of prevention programs including use of safer medical devices, immunization/vaccination programs, and safe clinical practices
- Illustrate an effective pathway for reporting exposure incidents and injuries
- Define processes for post-exposure medical treatment and prophylaxis
- Share global experiences from key stakeholders responsible for sharps safety and public health programs around the world
Save Your Seat
Why Use PleurX™ Catheter System
- Reduces hospital visits and prevents exposure to contagion
- The time-tested solution used to treat more than 500,000 patients since 1997
- Referenced in more than 35 peer-reviewed journal articles
- Reports a documented < 3% infection rate and < 5% occlusion rate
- Indicated for spontaneous pleurodesis (46% of patients achieve spontaneous pleurodesis at a median of 26.5 days)
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Video title here
Let's have a conversation
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
Pellentesque habitant morbi
- Tristique senectus et netus et malesuada
- Tristique senectus et netus et malesuada
- Tristique senectus et netus et malesuada
- Tristique senectus et netus et malesuada
Pellentesque habitant morbi
- Tristique senectus et netus et malesuada
- Tristique senectus et netus et malesuada
- Tristique senectus et netus et malesuada
- Tristique senectus et netus et malesuada
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Store Tab
360° rotation knob is effectively sized, contoured and located to enable easy instrument rotation.
360° rotation knob is effectively sized
360° rotation knob is effectively sized
360° rotation knob is effectively sized
Vascular access devices are touched numerous times, from insertion to removal?
Problems like infections and occlusions, dislodgement and phlebitis, may arise leading to vascular access device failure.
Occlusion
- A blocked catheter can prevent infusion or injection of a solution into a catheter and aspiration of blood from a catheter.1
- Occlusion is likely to happen when an infusion runs dry, flushing is inadequate, clamping sequence is improper or incompatible medications are infused.1
Dislodgement
- Catheter movement into or out of the insertion site may lead the tip to move to a suboptimal position, impeding continuous infusion, leading to edema, pain and change in skin color.2
Phlebitis
- The use of irritating solutions, not allowing skin antisepsis to dry, inadequate haemodilution, improper catheter size or stabilization technique, breaks in aseptic technique and non-occlusive dressing could cause phlebitis i.e inflammation of vein leading to pain, tenderness and erythema.3
Infiltration and extravasation
- Inappropriate insertion site, inadequate stabilization, difficult access history, medications that alter pain sensation, the disease that produces a change in the vasculature, use of deep veins with insufficient catheter length could all cause infiltration or extravasation.4
Catheter-related bloodstream infection (CRBSI)
- The catheter becomes the source of the infection and develops erythema, edema, pain, tenderness, and fever.5 Non-intact dressing or poor choice of insertion site can also lead to CRBSI.6
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
Uscid est ad quis et lam sitatium commoloribus solupta illaborum doloria alisci dioribus si quis porereh enianimus mollam, quo maxim quis ma senimus, alit,Deles etusapici am, inusdae commodi cupiderro doluptas acipsap elignatio omnihilla inihiliciu Denihit doluptamus ut ped ut eatinie ndandem. Quae. Olut exerios dipsum nis
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Ibus exped et ape
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Make a decisive move against vascular access infections now. Share your information to get a copy of Care Bundles, a collection of best practices. Count on our support right through the vascular access care continuum
References:
1. Infusion Therapy Standards of Practice. J Infus Nurs. 2021; 8th Edition : S 210
2. Infusion Therapy Standards of Practice. J Infus Nurs. 2021; 8th Edition : S 204
3. Infusion Therapy Standards of Practice. J Infus Nurs. 2021; 8th Edition : S 211
4. Infusion Therapy Standards of Practice. J Infus Nurs. 2021; 8th Edition : S 206,S 207
5. Infusion Therapy Standards of Practice. J Infus Nurs. 2021; 8th Edition : S 204
6. Safdar N, Maki DG. Int Care Med. 2004; 30(1): 65.
7. Helm RE, Klausner JD, Klemperer JD, Flint LM, Huang E. Accepted but unacceptable: peripheral IV catheter failure.J Infus Nurs. 2015;38(3):189-203.
8. Mandal A, Raghu K. Study on incidence of phlebitis following the use of peripheral intravenous catheter. J Family Med Prim Care 2019;8:2827-31
9. Cheung E, Baerlocher MO, Asch M, Myers A. Venous access: a practical review for 2009. Can Fam Physician. 2009;55(5):494-6.
10. Ullman AJ, Marsh N, Mihala G, Cooke M, Rickard CM. Complications of central venous access devices: a systematic review. Pediatrics. 2015;136(5):e1331-44.
11. Centers for Disease Control. Bloodstream infection event (central line-associated bloodstream infection and non-central line-associated bloodstream infection). Accessed on October 18, 2019, at https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf.
12. Vital signs: central line-associated blood stream infections. Centers for Disease Control and Prevention (CDC) website. https://www.cdc.gov/vitalsigns/pdf/2011-03-vitalsigns.pdf Published March 1, 2011. Accessed October 18, 2019.
13. Mehta Y, et al. Device-Associated Infection Rates in 20 Cities of India, Data Summary for 2004-2013: Findings of the International Nosocomial Infection Control Consortium. Infect. Control Hosp. Epidemiol. 2015;00(0): 1-10
14. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections.Clin Infect Dis. 2011;52(9):e162–e193. doi:10.1093/cid/cir257.
15. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-46.
16. Stevens V, Geiger K, Concannon C, Nelson RE, Brown J, Dumyati G. Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections. Clin Microbiol Infect. 2014;20(5):O318-24.
17. Helm RE, Klausner JD, Klemperer JD, Flint LM, Huang E. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurs. 2015;38(3):189-203.
18. Fields JM, Piela NE, Ku BS. Association between multiple IV attempts and perceived pain levels in the emergency department.J Vasc Access. 2014;15(6):514-8.